Description
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety ofRifaximinSoluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
Location: CPMC (San Francisco)
Please contact: ClinicalResearch@sutterhealth.org about study Salix RNLC3131 RED-C-3131